Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elaine Darnall"'
Autor:
Connie A. Haley, Patricia Macias, Supriya Jasuja, Betsy A. Jones, Marie-Claire Rowlinson, Roshni Jaimon, Pennelyn Onderko, Elaine Darnall, Maria E. Gomez, Charles Peloquin, David Ashkin, Neela D. Goswami
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 1, Pp 332-334 (2021)
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months posttre
Externí odkaz:
https://doaj.org/article/d74eb24cd9fc4764bf443d1161ecc1bb
Autor:
David Ashkin, Pennelyn Onderko, Charles A. Peloquin, Marie-Claire Rowlinson, Patricia Macias, Connie A. Haley, Betsy A. Jones, Roshni Jaimon, Maria E. Gomez, Supriya Jasuja, Neela D. Goswami, Elaine Darnall
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 1, Pp 332-334 (2021)
Emerging Infectious Diseases
Emerging Infectious Diseases
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months posttre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f79f2f02e141e749e62d983c07a84261
https://wwwnc.cdc.gov/eid/article/27/1/20-3766_article
https://wwwnc.cdc.gov/eid/article/27/1/20-3766_article
Autor:
Neela Goswami, Lakshmi Praveena Peddareddy, John Jereb, Angel Colon Semidey, Elaine Darnall, Patricia Macias, Supriya Jasuja, Karen Landers, Shom Dasgupta, Margaret Oxtoby, Christopher Spitters, Lana Dov, Masa Narita, Malini DaSilva, Tracina Cropper, Cricket Gullickson, David Ashkin, Connie Haley
Publikováno v:
Open Forum Infectious Diseases
Background In August 2019 the U.S. FDA approved pretomanid as part of a 6-month all-oral BPaL (bedaquiline, pretomanid, and linezolid) regimen for treating pulmonary extensively drug-resistant (XDR) or treatment-intolerant or nonresponsive multidrug-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bbc6806a3e968262a2dcf816c6a0c16
http://europepmc.org/articles/PMC8643925
http://europepmc.org/articles/PMC8643925